Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 6, Issue 2, pp. 201-208
PubMed
Published By
Print ISSN
Online ISSN
History
- Received May 1, 2017
- Revision received September 26, 2017
- Accepted December 20, 2017
- Published first January 5, 2018.
Article Versions
- Previous version (January 5, 2018 - 08:02).
- Previous version (January 10, 2018 - 07:32).
- You are viewing the most recent version of this article.
Copyright & Usage
©2018 American Association for Cancer Research.
Author Information
- Zuzana Berrong1,
- Mikayel Mkrtichyan1,
- Shamim Ahmad1,
- Mason Webb1,
- Eslam Mohamed1,
- Grigori Okoev1,
- Adelaida Matevosyan1,
- Rajeev Shrimali1,
- Rasha Abu Eid1,2,
- Scott Hammond3,
- John E. Janik1, and
- Samir N. Khleif1,*
- 1Georgia Cancer Center, Augusta University, Augusta, Georgia.
- 2The University of Aberdeen Dental School and Hospital, The Institute of Medicine, Medical Sciences and Nutrition, The University of Aberdeen, Scotland, United Kingdom.
- 3MedImmune Inc., Gaithersburg, Maryland.
- ↵*Corresponding Author:
Samir N. Khleif, Augusta University, CN 4132, 1410 Laney Walker Boulevard, Augusta, GA 30912. Phone: 706-721-0570; Fax: 706-721-8787; E-mail: SKhleif{at}augusta.edu
February 2018
Volume 6, Issue 2
Volume 6, Issue 2
Antigen-Specific Antitumor Responses Induced by OX40 Agonist Are Enhanced by the IDO Inhibitor Indoximod
Jump to section
Advertisement